NCAM1 and schizophrenia: Observations of altered PSA-NCAM in brains of patients with schizophrenia, bipolar disorder, major depression, and drug-refractory temporal lobe epilepsy indicate a functional dysregulation of the glycosylation process in mental illness21–26.